Skip to main content
SpringerLink
Log in

Treatment of gestational trophoblastic tumors

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Gestational trophoblastic tumors (invasive mole, choriocarcinoma, and placental site trophoblastic tumor) should be classified according to the National Cancer Institute (NCI), World Health Organization (WHO), and International Federation of Gynecology and Obstetrics (FIGO) criteria into nonmetastatic, low-risk metastatic, and high-risk metastatic categories. Nonmetastatic tumors (FIGO Stage I) can be treated with a variety of single-agent methotrexate or actinomycin D protocols, resulting in cure of essentially all patients. Metastatic low-risk tumors (FIGO Stages II and III, WHO score < 8) should be treated with 5-day dosage schedules of methotrexate or actinomycin D, with cure rates approaching 100%. Metastatic high-risk tumors (FIGO Stage IV, WHO score > 7) require combination chemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO) with or without adjuvant radiation therapy and surgery to achieve cure rates of 80% to 90%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gestational Trophoblastic Disease. Edited by Hancock BW,Newlands ES, Berkowitz RS. London: Chapman & Hall Medical; 1997.

    Google Scholar 

  2. Lurain JR, Casanova LA, Miller DS, et al.: Prognostic factors in gestational trophoblastic tumors. Am J Obstet Gynecol 1991, 64:611–616.

    Google Scholar 

  3. Soper JT, Evans AC, Conway MR, et al.: Evaluation of prognostic factors and staging in gestational trophoblastic tumors. Obstet Gynecol 1994, 84:969–973.

    PubMed  CAS  Google Scholar 

  4. Hammond CB, Borchert LG, Tyrey L, et al.: Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol 1973:115-451.

  5. International Federation of Gynecology and Obstetrics: Annual Report on the Results of Treatment in Gynecological Cancer, edn 22. Stockholm: FIGO; 1994.

    Google Scholar 

  6. World Health Organization Scientific Group: Gestational trophoblastic disease. In Technical Report Series 692. Geneva: World Health Organization; 1983.

    Google Scholar 

  7. Lurain JR, Elfstrand EP: Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1995, 172:574–579.

    Article  PubMed  CAS  Google Scholar 

  8. Berkowitz RS, Goldstein DP, Bernstein MR: Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986, 23:111–118.

    Article  PubMed  CAS  Google Scholar 

  9. Bagshawe KD, Dent J, Newlands ES, et al.: The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours. Br J Obstet Gynecol 1989, 96:795–802.

    CAS  Google Scholar 

  10. Wong LC, Choo YC, Ma HK: Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 1985, 152:59–62.

    PubMed  CAS  Google Scholar 

  11. Homesley HD, Blessing JA, Schlaerth J, et al.: Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1988, 72:413–418.

    PubMed  CAS  Google Scholar 

  12. Hoffman MS, Fiorica JV, Gleeson NC, et al.: A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 1996, 60:292–294.

    Article  PubMed  CAS  Google Scholar 

  13. Berkowitz RS, Goldstein DP, Bernstein MR: Metastatic infusion with folinic acid in primary therapy of nonmetastatic gestational trophoblastic tumors. Gynecol Oncol 1990, 36:56–59.

    Article  PubMed  CAS  Google Scholar 

  14. Elit L, Covens A, Osborne R, et al.: High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 1994, 54:282–287.

    Article  PubMed  CAS  Google Scholar 

  15. Wong LC, Ngan HYS, Cheng DKL, et al.: Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 2000, 183:1579–1582.

    Article  PubMed  CAS  Google Scholar 

  16. Smith EB, Weed JC Jr, Tyrey L, et al.: Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexatefolinic acid. Am J Obstet Gynecol 1982, 144:88–92.

    PubMed  CAS  Google Scholar 

  17. Gleeson NC, Finan MA, Fiorica JV, et al.: Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid. Eur J Gynecol Oncol 1993, XIV:461–465.

    Google Scholar 

  18. Osathanondh R, Goldstein DP, Pastorfide GB: Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 1975, 36:863–866.

    Article  PubMed  CAS  Google Scholar 

  19. Petrilli ES, Morrow CP: Actinomycin D toxicity in the treatment of trophoblastic disease. A comparison of the 5-day course to single-dose administration. Gynecol Oncol 1980, 9:18–22.

    Article  PubMed  CAS  Google Scholar 

  20. Kohorn EI: Decision making for chemotherapy administration in patients with low-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer 1996, 6:279–285.

    Article  Google Scholar 

  21. Twiggs LB: Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: cost-effective chemotherapy. Gynecol Oncol 1982, 16:190–195.

    Article  Google Scholar 

  22. Schlaerth JB, Morrow CP, Nalick RH, et al.: Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. Gynecol Oncol 1984, 19:53–56.

    Article  PubMed  CAS  Google Scholar 

  23. Petrilli ES, Twiggs LB, Blessing JA, et al.: Single-dose actinomycin D treatment for non-metastatic gestational trophoblastic disease. Cancer 1987, 60:2173–2176.

    Article  PubMed  CAS  Google Scholar 

  24. Smith JP: Chemotherapy in gynecologic cancer. Clin Obstet Gynecol 1975, 18:113–116.

    Article  Google Scholar 

  25. Rose PG, Piver MS: Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease. J Surg Oncol 1989, 41:148–152.

    Article  PubMed  CAS  Google Scholar 

  26. Roberts JP, Lurain JR: Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996, 174:1917–1924.

    Article  PubMed  CAS  Google Scholar 

  27. DuBeshter B, Berkowitz RS, Goldstein DP, et al.: Management of low-risk gestational tumors. J Reprod Med 1991, 36:36–39.

    PubMed  CAS  Google Scholar 

  28. Soper JT, Clarke-Pearson DL, Berchuck A, et al.: Five-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 1994, 54:76–79.

    Article  PubMed  CAS  Google Scholar 

  29. Lurain JR: Management of high-risk gestational trophoblastic disease. J Reprod Med 1998, 43:44–52.

    PubMed  CAS  Google Scholar 

  30. Bower M, Newlands ES, Holden L, et al.: EMA/CO for high-risk gestational trophoblastic tumors; results from a cohort of 272 patients. J Clin Oncol 1997, 15:2636–2643.

    PubMed  CAS  Google Scholar 

  31. Kim SJ, Bae SN, Kim JH, et al.: Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998, 71:247–253.

    Article  PubMed  CAS  Google Scholar 

  32. Matsui H, Suzuka K, Iitsuka Y, et al.: Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol 2000, 78:28–31.

    Article  PubMed  CAS  Google Scholar 

  33. Escobar PF, Bozorgi K, Fishman DA, et al.: Combination chemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine (EMACO) for treatment of high-risk gestational trophoblastic tumors. XIth World Congress on Gestational Trophoblastic Diseases, Santa Fe, NM; October 30, 2001.

    Google Scholar 

  34. Newlands ES, Mulholland PJ, Holden L, et al.: Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000, 18:854–859.

    PubMed  CAS  Google Scholar 

  35. Small W Jr, Lurain JR, Shetty RM, et al.: Gestational trophoblastic disease metastatic to the brain. Radiology 1996, 200:277–280.

    PubMed  Google Scholar 

  36. Rustin GJ, Newlands ES, Begent RHJ, et al.: Weekly alternating etoposide, methotrexate, actinomycin D/ vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 1989, 7:900–904.

    PubMed  CAS  Google Scholar 

  37. Mutch DG, Soper JT, Babcock CJ: Recurrent gestational trophoblastic disease. Cancer 1990, 66:978–982.

    Article  PubMed  CAS  Google Scholar 

  38. Tomodo Y, Arii Y, Kaseki S, et al.: Surgical indications for resection of pulmonary metastases of choriocarcinoma. Cancer 1980, 46:2723–2730.

    Article  Google Scholar 

  39. Vogelzang RL, Nemcek AA, Skrtic Z, et al.: Uterine arteriovenous malformations: primary treatment with therapeutic embolization. J Vasc Intervent Radiol 1991, 2:517–522.

    Article  CAS  Google Scholar 

  40. Newlands ES, Bower M, Fisher RA, et al.: Management of placental site trophoblastic tumors. J Reprod Med 1998, 43:53–59.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. John I. Brewer Trophoblastic Disease Center, Department of Obstetrics and Gynecology Northwestern University Medical School, Prentice Women's Hospital, 333 East Superior Street, Suite 420, 60611, Chicago, IL, USA

    John R. Lurain MD

Authors
  1. John R. Lurain MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lurain, J.R. Treatment of gestational trophoblastic tumors. Curr. Treat. Options in Oncol. 3, 113–124 (2002). https://doi.org/10.1007/s11864-002-0057-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-002-0057-5

Keywords

Search

Navigation